SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ferdinando Fusco, Gianluca D'Anzeo, Aurelio Sessa, Gianna Pace, Andrea Rossi, Marco Capece, Roberta d'Emmanuele di Villa Bianca, BPH/LUTS and ED: Common Pharmacological Pathways for a Common Treatment, The Journal of Sexual Medicine, 2013, 10, 10
  2. 2
    Andrew James Wardle, Robert M. R. Tulloh, Evolving Management of Pediatric Pulmonary Arterial Hypertension: Impact of Phosphodiesterase Inhibitors, Pediatric Cardiology, 2013, 34, 2, 213

    CrossRef

  3. 3
    Stefan Ückert, Markus A Kuczyk, Matthias Oelke, Phosphodiesterase inhibitors in clinical urology, Expert Review of Clinical Pharmacology, 2013, 6, 3, 323

    CrossRef

  4. 4
    Narayana Kilarkaje, Mariam H.M. Yousif, Ahmed Z. El-Hashim, Batoul Makki, Saghir Akhtar, Ibrahim F. Benter, Role of angiotensin II and angiotensin-(1–7) in diabetes-induced oxidative DNA damage in the corpus cavernosum, Fertility and Sterility, 2013, 100, 1, 226

    CrossRef

  5. 5
    Zhen Wang, Difeng Zhu, Xiaochun Yang, Jianfeng Li, Xiangrui Jiang, Guanghui Tian, Nicholas Kenneth Terrett, Jie Jin, Honghai Wu, Qiaojun He, Bo Yang, Jingshan Shen, The Selectivity and Potency of the New PDE5 Inhibitor TPN729MA, The Journal of Sexual Medicine, 2013, 10, 11
  6. 6
    Joseph J. Keller, Yi-Kuang Chen, Herng-Ching Lin, A Case-Control Analysis on the Association Between Erectile Dysfunction and Sudden Sensorineural Hearing Loss in Taiwan, The Journal of Sexual Medicine, 2012, 9, 5
  7. 7
    Monique P. Curran, Tadalafil, Drugs & Aging, 2012, 29, 9, 771

    CrossRef